Editorial | Open Access | 18 Dec 2018

Acknowledgement to reviewers of Cancer Drug Resistance in 2018

Views: 1146 | Downloads: 814 | Cited:

Cancer Drug Resistance Editorial Office

Cancer Drug Resist 2018;1:198-9.

10.20517/cdr.2018.29 | © The Author(s) 2018.

Author Information

Article Notes

Cite This Article

Download PDF 0 16

The editors of the Cancer Drug Resistance would like to take this opportunity to express their sincere gratitude to the reviewers and guest editors for assessing manuscripts in 2018 [Table 1].

Table 1

Names of reviewers and guest editors

Names
Amstutz, Ursula	Jansen, Gerrit
Ahmad, Aamir	Jiang, Zhao
Balboni, Beatrice	Joerger, Markus
Ciriza, Jesús	Kwok, Hang Fai
Cloos, Jacqueline	Link, Wolfgang
Del Re, Marzia	Marchesi, Federica
El Hassouni, Btissame	Matsuura, Yoshiyuki
Fenton, Tim	Michaelis, Martin
Fiandalo, Michael	Mini, Enrico
Firuzi, Omid	Nobili, Stefania
Gan, Boyi	Nowak-Sliwinska, Patrycja
Garajová, Ingrid	Pasternak, Amy
Garrett, Michelle	Perego, Paola
Giovannetti, Elisa	Phillips, Roger M
Gong, Li	Pore, Milind
Griffiths, Elizabeth	Rodriguez, Jose Antonio
Huang, Shiliang	Rosière, Rémi
Huisman, M.C.	Wass, Mark
Hussain, Suleman	Zaffaroni, Nadia

The listed reviewers have our sincere gratitude. They can also get their Reviewer Recognition Certificates by building their peer review profiles on Publons (https://publons.com).

Declarations

Authors’ contributions

Writing and revision of the article and approved the final version: Cancer Drug Resistance Editorial Office

Availability of data and materials

Not applicable.

Financial support and sponsorship

None.

Conflicts of interest

All authors declared that there are no conflicts of interest.

Ethical approval and consent to participate

Not applicable.

Consent for publication

Not applicable.

Cite This Article

Export citation file: BibTeX | RIS

OAE Style

Cancer Drug Resistance Editorial Office. Acknowledgement to reviewers of Cancer Drug Resistance in 2018. Cancer Drug Resist 2018;1:198-9. http://dx.doi.org/10.20517/cdr.2018.29

AMA Style

Cancer Drug Resistance Editorial Office. Acknowledgement to reviewers of Cancer Drug Resistance in 2018. Cancer Drug Resistance. 2018; 1(4): 198-9. http://dx.doi.org/10.20517/cdr.2018.29

Chicago/Turabian Style

Cancer Drug Resistance Editorial Office, . 2018. "Acknowledgement to reviewers of Cancer Drug Resistance in 2018" Cancer Drug Resistance. 1, no.4: 198-9. http://dx.doi.org/10.20517/cdr.2018.29

ACS Style

Cancer Drug, Resistance Editorial Office. Acknowledgement to reviewers of Cancer Drug Resistance in 2018. Cancer Drug Resist. 2018, 1, 198-9. http://dx.doi.org/10.20517/cdr.2018.29

About This Article

Copyright

© The Author(s) 2018. Open Access This article is licensed under a Creative Commons Attribution 4.0 International License (https://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, sharing, adaptation, distribution and reproduction in any medium or format, for any purpose, even commercially, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.

Data & Comments

Data

Views

1146

Downloads

814

Citations

Comments

Comments

Comments must be written in English. Spam, offensive content, impersonation, and private information will not be permitted. If any comment is reported and identified as inappropriate content by OAE staff, the comment will be removed without notice. If you have any queries or need any help, please contact us at support@oaepublish.com.